Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINORELBINE for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 155 adverse event reports in the FDA FAERS database where VINORELBINE was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for VINORELBINE

Side Effect Reports % Deaths Hosp.
Off label use 644 12.4% 139 258
Malignant neoplasm progression 624 12.1% 107 110
Disease progression 526 10.2% 135 95
Neutropenia 517 10.0% 75 175
Nausea 504 9.7% 77 227
Drug ineffective 391 7.6% 78 84
Fatigue 373 7.2% 76 162
Diarrhoea 371 7.2% 58 174
Vomiting 342 6.6% 44 173
Anaemia 335 6.5% 56 123
Thrombocytopenia 308 6.0% 72 92
Febrile neutropenia 305 5.9% 58 194
Pyrexia 296 5.7% 57 165
Dyspnoea 263 5.1% 57 124
Asthenia 250 4.8% 29 96

Other Indications for VINORELBINE

Breast cancer (641) Breast cancer metastatic (623) Product used for unknown indication (604) Hodgkin's disease (333) Her2 positive breast cancer (309) Non-small cell lung cancer (254) Lung adenocarcinoma (197) Lung neoplasm malignant (160) Chemotherapy (148) Invasive ductal breast carcinoma (133)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

VINORELBINE Full Profile All Diffuse large b-cell lymphoma Drugs VINORELBINE Demographics VINORELBINE Timeline